Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

N-(pyridine-3-ylmethyl)-5-(7-hydroxy-2,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-yl)-2-methylpenta-2,4-dienamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
N-(pyridine-3-ylmethyl)-5-(7-hydroxy-2,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-yl)-2-methylpenta-2,4-dienamide
Unique ID
C573938
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C573938
Entry Term(s)
2-methylcoprophilinamide
AMF-26
M-COPA compound
Registry Numbers
0
Heading Mapped to
*Naphthols
*Pyridines
Frequency
8
Note
an ADP-ribosylation factor 1 inactivator; has antineoplastic and angiogenesis inhibitory activity; structure in first source
Source
Int J Cancer. 2012 Jul 15;131(2):310-21.
Indexing Information
Anti-Inflammatory Agents, Non-Steroidal
Date of Entry
2012/07/29
Revision Date
2017/02/10
N-(pyridine-3-ylmethyl)-5-(7-hydroxy-2,6,8-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-yl)-2-methylpenta-2,4-dienamide Preferred
AMF-26 Narrower
page delivered in 0.012s